Orchid receives US FDA approvals for three Cefuroxime Inj. ANDAs

The Chennai-based pharma major, Orchid Chemicals & Pharmaceuticals Ltd (Orchid) today announced that it has received approvals from the US FDA for three of its ANDAs (Abbreviated New Drug Application) for Cefuroxime for Injection, 750 mg & 1.5 g vials (infusion packs), 7.5 g (pharmacy bulk pack) and 1.5 g vial. Cumulatively, Orchid has secured 28 ANDA approvals.